PharmD, PhD, Dr. Kawas has led the company in business and financial growth through two oversubscribed financing rounds. The funds raised will support and accelerate growth of the company and take the lead candidate through the early stages of human testing.
Dr. Kawas was named one of Seattle’s Most Influential People by Seattle Magazine (November 2015) and one of the Women to Watch in Life Sciences by the Washington Biotechnology and Biomedical Association (July 2015). She also serves on multiple boards, including the Washington Governor’s Life Advisory Board and the Scientific Review Board for the Alzheimer’s Drug Discovery Foundation.
She earned a doctorate in molecular pharmacology in 2011, and received the Harriett B. Rigas and Karen DePauw awards for academic achievement and leadership skills. She holds a Doctor of Pharmacy (PharmD.) from the University of Jordan (2008). Dr. Kawas also completed the Executive Training Program at the Foster School of Business, University of Washington (2014).